Stony Brook University Medical Center Cancer Center
Stony Brook, New York 11794
We've found
1 trials
at this facility
Non-Small Cell Lung Cancer Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage IIB or IIIA Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
